Fast-Track Cardiovascular Assessment for Suspicion of Cardiovascular Events on Immunecheckpoint Inhibitors
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorInstitut Mutualiste Montsouris
About this trial
Prospective study cohort on patients addressed for suspected cardiovascular event on immune checkpoint inchibitors.
Longitudinal prospective single center cohort. Inclusion criteria: all patient willing to particiupate seen in the cardio-oncology unit at our institution for the suspicion of heart failure, atherosclerosis related event, Tako Tsubo, arrhymias, pericarditis, myocarditis on antiPD1, antiPDL1, or antiCTLA4 immune checkpoint inhibitors.
Description of patients characteristics, investigations, diagnosis after multidisciplinary meeting, outcomes.
Eligibility criteria
Qualifiers
all patient referred to the cardio oncology unit for suspected immune related cardiovascular complication on immune checkpoint inhibitors
Disqualifiers
none
Trial design
Treatments tested in this trial
- No intervention for research purposes only
Treatment groups
No treatment groups listed
Locations
1Intitut Mutualiste Montsouris75014, Paris France
Sponsors and collaborators
Institut Mutualiste Montsouris
Lead sponsor
Source ClinicalTrials.gov